Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose-Ignacio Rodriguez-Barbosa

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Transplantation|October 8, 2011
B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicityMaria-Luisa del Rio, Josef Kurtz, Claudia Perez-Martinez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2012
Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reactionMaria-Luisa del Rio, Nick D Jones, Leo Buhler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
CX3CR1+ c-kit+ bone marrow cells give rise to CD103+ and CD103- dendritic cells with distinct functional propertiesMaria-Luisa del Rio, Jose-Ignacio Rodriguez-Barbosa, Jasmin Bölter, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 2, 2025
A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growthMaria-Luisa Del Rio, Oscar-Mariano Nuero-Garcia, Giovanna Roncador, et al.
Transplantation|September 17, 2014
Therapeutic blockade of LIGHT interaction with herpesvirus entry mediator and lymphotoxin β receptor attenuates in vivo cytotoxic allogeneic responsesMaria-Luisa del Rio, Carlos Fernandez-Renedo, Stefanie Scheu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph nodeGabriele Hintzen, Lars Ohl, Maria-Luisa del Rio, et al.
Frontiers in Immunology|April 10, 2023
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1<sup>-</sup> stem cell-like T cells over PD-1<sup>+</sup> T cells curbing tumor progressionMaria-Luisa Del Rio, Carla Yago-Diez de Juan, Giovanna Roncador, et al.
Mabs|January 12, 2016
Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cellsMaria-Luisa del Rio, Carlos Fernandez-Renedo, Olivier Chaloin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 6, 2016
Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrierMaria-Luisa Del Rio, Ana Maria Bravo Moral, Carlos Fernandez-Renedo, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 30, 2021
The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejectionMaria-Luisa Del Rio, Tuan H Nguyen, Laurent Tesson, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Transplantation|October 8, 2011
B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicityMaria-Luisa del Rio, Josef Kurtz, Claudia Perez-Martinez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2012
Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reactionMaria-Luisa del Rio, Nick D Jones, Leo Buhler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
CX3CR1+ c-kit+ bone marrow cells give rise to CD103+ and CD103- dendritic cells with distinct functional propertiesMaria-Luisa del Rio, Jose-Ignacio Rodriguez-Barbosa, Jasmin Bölter, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 2, 2025
A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growthMaria-Luisa Del Rio, Oscar-Mariano Nuero-Garcia, Giovanna Roncador, et al.
Transplantation|September 17, 2014
Therapeutic blockade of LIGHT interaction with herpesvirus entry mediator and lymphotoxin β receptor attenuates in vivo cytotoxic allogeneic responsesMaria-Luisa del Rio, Carlos Fernandez-Renedo, Stefanie Scheu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph nodeGabriele Hintzen, Lars Ohl, Maria-Luisa del Rio, et al.
Frontiers in Immunology|April 10, 2023
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1<sup>-</sup> stem cell-like T cells over PD-1<sup>+</sup> T cells curbing tumor progressionMaria-Luisa Del Rio, Carla Yago-Diez de Juan, Giovanna Roncador, et al.
Mabs|January 12, 2016
Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cellsMaria-Luisa del Rio, Carlos Fernandez-Renedo, Olivier Chaloin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 6, 2016
Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrierMaria-Luisa Del Rio, Ana Maria Bravo Moral, Carlos Fernandez-Renedo, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 30, 2021
The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejectionMaria-Luisa Del Rio, Tuan H Nguyen, Laurent Tesson, et al.
Pageof 4